granted
on 19 Jan 2024
Last Applicant/ Owned by
86 Morris Avenue
Summit
NJ
07901
Serial Number
88801374 filed on 18th Feb 2020
Registration Number
N/A
Correspondent Address
Xiomara Triana
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloprolRead More
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, antifungal preparations, antivirals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer and cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy and T Cell therapy use; Pharmaceutical preparations for human use, namely, stem cells for medical and medical clinic purposes
No 88801374
No Service/Collective Mark
No 00138714-US
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
20th Jan 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
19th Jan 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
19th Jan 2024 | SOU EXTENSION 5 GRANTED |
03rd Jan 2024 | SOU TEAS EXTENSION RECEIVED |
03rd Jan 2024 | SOU EXTENSION 5 FILED |
15th Jul 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
13th Jul 2023 | SOU TEAS EXTENSION RECEIVED |
13th Jul 2023 | SOU EXTENSION 4 FILED |
13th Jul 2023 | SOU EXTENSION 4 GRANTED |
26th Jan 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |